| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19b64f263e0e14024e8d5ecc6af01945 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 |
| filingDate |
1985-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
1987-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
FR-2589735-A1 |
| titleOfInvention |
ANTI-CONCEPTIONAL COMPOSITIONS CONTAINING AN ESTROGEN AND A PROGESTIVE |
| abstract |
THE INVENTION CONCERNS ANTICONCEPTIONAL COMPOSITIONS PROTECTING AGAINST HORMONE-DEPENDENT CANCERS OF THE BREAST AND ENDOMETRIC CONTAINING AN EESTROGEN ASSOCIATED WITH A PROGESTATIVE. ACCORDING TO THE INVENTION, THE DOSE OF ESTROGEN IS A MINIMUM DOSE TO ENSURE ANOVULATION AND THE DOSE OF PROGESTATIVE IS SUCH AS THE RATIO OF THE ACTUAL BIOLOGICAL EFFICIENCY OF THE PROGESTATIVE TO THAT OF THE EESTROGEN IS 1.5 TIMES TO 3 TIMES HIGHER THAN IN CLASSIC ANTICONCEPTIONAL PRODUCTS. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1319404-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1319404-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5276022-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1935423-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1310257-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0309263-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1310257-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0309263-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2746300-A1 |
| priorityDate |
1985-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |